Works matching IS 09395555 AND DT 2003 AND VI 82 AND IP 11


Results: 15
    1
    2
    3
    4
    5
    6
    7

    A randomized multicenter open label phase II study to determine the safety and efficacy of induction therapy with imatinib (Glivec, formerly STI571) in comparison with standard induction chemotherapy in elderly (>55 years) patients with Philadelphia chromosome-positive (Ph<sup>+</sup>/BCR-ABL<sup>+</sup>) acute lymphoblastic leukemia (ALL) (CSTI571ADE 10)

    Published in:
    Annals of Hematology, 2003, v. 82, n. 11, p. 716, doi. 10.1007/s00277-003-0728-8
    By:
    • Wassmann, B.;
    • Gökbuget, N.;
    • Scheuring, U. J.;
    • Binckebanck, A.;
    • Reutzel, R.;
    • Gschaidmeier, H.;
    • Hoelzer, D.;
    • Ottmann, O. G.;
    • Group, GMALL Study
    Publication type:
    Article
    8
    9
    10
    11

    Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia— a randomized, placebo-controlled, double-blind safety and efficacy study

    Published in:
    Annals of Hematology, 2003, v. 82, n. 11, p. 677, doi. 10.1007/s00277-003-0737-7
    By:
    • Geissler, K.;
    • Liu Yin, J. A.;
    • Ganser, A.;
    • Sanz, M. A.;
    • Szer, J.;
    • Raghavachar, A.;
    • Hoelzer, D.;
    • Martinez, C.;
    • Taylor, K.;
    • Kanz, L.;
    • To, L. B.;
    • Archimbaud, E.
    Publication type:
    Article
    12
    13

    November 2003.

    Published in:
    Annals of Hematology, 2003, v. 82, n. 11, p. 721, doi. 10.1007/s00277-003-0750-x
    Publication type:
    Article
    14
    15